Designer broad-spectrum polyimidazolium antibiotics

Designer broad-spectrum polyimidazolium antibiotics

© 2020 National Academy of Sciences. All rights reserved. For a myriad of different reasons most antimicrobial peptides (AMPs) have failed to reach clinical application. Different AMPs have different shortcomings including but not limited to toxicity issues, potency, limited spectrum of activity, or...

Full description

Bibliographic Details
Main Authors: Zhong, Wenbin, Shi, Zhenyu, Mahadevegowda, Surendra H, Liu, Bo, Zhang, Kaixi, Koh, Chong Hui, Ruan, Lin, Chen, Yahua, Zeden, Merve S, Pee, Carmen JE, Marimuthu, Kalisvar, De, Partha Pratim, Ng, Oon Tek, Zhu, Yabin, Chi, Yonggui Robin, Hammond, Paula T, Yang, Liang, Gan, Yunn-Hwen, Pethe, Kevin, Greenberg, E Peter, Gründling, Angelika, Chan-Park, Mary B
Other Authors: Koch Institute for Integrative Cancer Research at MIT
Format: Article
Language:English
Published: Proceedings of the National Academy of Sciences 2021
Online Access:https://hdl.handle.net/1721.1/133954

Internet

https://hdl.handle.net/1721.1/133954

Similar Items